I am a healthcare professional

Notice


Welcome to MEDICALLY. This website is a non-promotional international resource intended to facilitate transparent scientific exchange regarding developments in medical research and disease management. It is intended for healthcare professionals outside the United Kingdom (UK) and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Roche and Genentech do not support, endorse or recommend the unapproved use of any compound or service in your jurisdiction, including those discussed on this website.


Please refer to local product information for any medicinal products mentioned. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same. Healthcare professionals outside the US are required to register and log-in to access the full range of content available on this website.


By clicking on one of the healthcare professional buttons below, you acknowledge you have read and understood this message and that you are requesting access to MEDICALLY. If you are not a healthcare professional, please use the other links below to access information relevant to you.


Cookies


We use cookies on this site to enable the site to function properly and to enhance your user experience. Cookies are files stored in your browser, which most websites use to personalize your web experience. Your information will only be used to provide information that is relevant to you. It will not be used for any other purpose. If you wish to restrict or block cookies, which are set on your device, then you can do this through your browser settings.


You can find out more about cookies by browsing our Privacy Policy.

 

For healthcare professionals in Another Country browse medically.roche.com.

Not a healthcare professional? For individuals outside the US, browse Roche's patient website or roche.com. For individuals in the US, browse gene.com.

External site

The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.

Leave site
Roche and Genentech at

ERA 2025

-
07:45 AM
Duration 90mins Vienna, Austria
Effects of obinutuzumab on urinary biomarkers in lupus nephritis: a post hoc exploratory analysis of the Phase II NOBILITY study
Mejia-Vilet JM, Clarke HJ, Lanza B, Anania V, Pendergraft III WF, Omachi TA, Parodis I, Jones R, Lightstone L, Rovin BH, Raghu H
Duration 91mins Vienna, Austria
INShore: Phase III, multicentre, randomised, open-label study of efficacy and safety of obinutuzumab vs MMF in patients with childhood-onset idiopathic nephrotic syndrome
Hogan J, Ding J, Greenbaum L, Mizerska-Wasiak M, Nozu K, Watanabe A, Boston H, Chen DC, Lanza B, Lehane P
Duration 90mins Vienna, Austria
Patient-reported fatigue is improved or maintained over 2 years in patients receiving crovalimab▼ for paroxysmal nocturnal haemoglobinuria (PNH)
H. STAUNTON, J. STEFANI, P. LEON
07:45 AM
Duration 92mins Vienna, Austria
Low rate of infusion-related reactions and high treatment adherence with obinutuzumab in patients with active lupus nephritis: analysis of the NOBILITY and REGENCY studies
Jones R, Rovin BH, Sehgal H, Kirchner P, Yoo B, Hassan I, Schindler T, Martins E, Pendergraft W, Garg JP, Vital EM, Lightstone L
01:00 PM
Duration 90mins Vienna, Austria
Suppression of complement alternative pathway by monthly dosing of sefaxersen, a novel antisense oligonucleotide therapy in development for IgAN
Jeannette Lo, Nelson Guerreiro, Nadine Schmit, Lixuan Yin, Terry Barrett, Ji Cheng, Vishal Duggal, Gary Brice
Coming soon